The latest headlines across every section, pulled from official and open-access sources.
On 17 May 2026, the World Health Organization (WHO) declared the Ebola virus disease outbreak caused by Bundibugyo virus in the Democratic Republic of the Congo (DRC) and Uganda a Public Health Emergency of International Concern.
Community-acquired pneumonia (CAP) accounts for 1.4 million emergency department visits and 740 000 hospitalizations annually in the US. Author Andre Kumar, MD, MEd, of Stanford University School of Medicine joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the use of point-of-care ultrasound for diagnosis of CAP. Related Content: Point-of-Care Ultrasound for the Diagnosis of Pneumonia Bedside Lung Ultrasound in Emergency (BLUE) for Evaluation of Dyspnea
The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule vcramer Wed, 06/03/2026 - 14:58 Official Statement The American Diabetes Association’s Statement on the OMB’s Financial Assistance Proposed Rule Arlington, Va. June 3, 2026 The White House Office of Management and Budget (OMB) recently proposed a rewrite of the Guidance for Federal Financial Assistance, updating regulations that dictate reporting and performance requirements for federal grant recipients. The proposed rule implements many of the changes President Trump announced in an executive order…
Statement from the American Diabetes Association on the CMS’s Medicaid Work Requirements Interim Final Rule vcramer Wed, 06/03/2026 - 14:50 Official Statement Statement from the American Diabetes Association on the CMS’s Medicaid Work Requirements Interim Final Rule Arlington, Va. June 3, 2026 This week, the Centers for Medicare & Medicaid Services (CMS) released an interim final rule implementing the new community engagement requirements for Medicaid beneficiaries included in healthcare and tax legislation Congress passed last summer. Beginning January 1, 2027…
Artificial Intelligence (AI) is rapidly reshaping health plan operations. While some organizations are actively piloting or scaling AI solutions, others are still determining where to begin. Regardless of where your organization sits on the AI adoption curve, scaling AI responsibly, transparently and effectively is foundational. Across the industry, initial efforts have focused on defining governance […] The post Shape the Future of AI in Prior Authorization: Apply to Join NCQA’s Learning Collaborative appeared first on NCQA .
This week, we discuss left atrial appendage closure for atrial fibrillation, oxygen strategies in respiratory failure, an all-oral treatment for acute myeloid leukemia, CAR T-cell therapy enabling kidney transplantation, and a case of a neuroepithelial tumor that developed after gene therapy. We review childhood vaccine hesitancy, follow a complex diagnostic case, and examine Perspectives on corporatization in medicine, famine and war, and the future of health care systems.
Options abound for hospitals looking to capitalize on these new data transfer technologies, but so do potential pitfalls. For any hospital considering adopting these new solutions, here are some of the key questions and considerations that should be top of mind. The post New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment appeared first on MedCity News .
Rural healthcare has always run on ingenuity, resilience, and community trust. What has too often been missing is the infrastructure strong enough to match that and sustain it at scale. That is what makes this moment different. The post Building the Backbone of Rural Health: Meeting the Reality on the Ground appeared first on MedCity News .
The chair of the NHS’s groundbreaking new online hospital trust has been named as business leader and former supermarket chief executive John Browett. NHS Online, which will provide virtual specialist care for patients through the NHS App and video consultations, has now been formally established as the Online NHS Trust. John is a former chief […]
EMA’s Emergency Task Force (ETF) is engaging with the African Medicines Agency (AMA) and its national regulatory authorities (NRAs), leveraging expertise from the WHO-AFRO…
Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of individual units. — AVEVA Drug Delivery Systems, Inc. · Class III · Ongoing
Failed Stability Specifications — AbbVie Inc. · Class III · Ongoing
GE HealthCare has become aware of an unlikely situation where potential loss of ECG and SpO2 monitoring involving ApexPro CARESCAPE Telemetry Server (CTS) v5.0 and v6.0, can result from a persistent NO COMM or OFF NETWORK condition at the CARESCAPE Central Station or CIC Pro Clinical Information Center (Central Station). — GE Medical Systems Information Technologies Inc · Class II · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Retrospective submission for following issues identified: 1. Alarm failures, power-path faults, electrical-short risks, and inaccurate motor-current sensing were identified in certain AIC consoles. 2. There is improper alignment between the purge cassette and the motor drive in the AIC. This can result in a piston block event and lead to the inability to … — Abiomed, Inc. · Class I · Ongoing
GE HealthCare has become aware of an unlikely situation where potential loss of ECG and SpO2 monitoring involving ApexPro CARESCAPE Telemetry Server (CTS) v5.0 and v6.0, can result from a persistent NO COMM or OFF NETWORK condition at the CARESCAPE Central Station or CIC Pro Clinical Information Center (Central Station). — GE Medical Systems Information Technologies Inc · Class II · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Specific Medline Kits contain Cardinal Health Monoject 1mL Luer Lock Syringes, Tuberculin Print, Sterile. Cardinal Health has recalled these syringes because the outer carton and blister pack are labeled as a 1 mL Luer Lock Tuberculin Syringe (Product Code 1180100777), but the syringes inside are U-100 insulin syringes. — Medline Industries, LP · Class II · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system. — Bolton Medical Inc. · Class I · Ongoing
Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints. — Medline Industries, LP · Class I · Ongoing